The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Pathogenesis, prevention, diagnosis and treatment of breast cancer
Open accessAbstract
Breast cancer is the most common cancer affecting women worldwide. Prediction models stratify a woman's risk for developing cancer and can guide screening recommendations based on the presence of known and quantifiable hormonal, environmental, personal, or genetic risk factors. Mammography remains the mainstay breast cancer screening and detection but magnetic resonance imaging and ultrasound have become useful diagnostic adjuncts in select patient populations. The management of breast cancer has seen much refinement with increased specialization and collaboration with multidisciplinary teams that include surgeons, oncologists, radiation oncologists, nurses, geneticist, reconstructive surgeons and patients. Evidence supports a less invasive surgical approach to the staging and management of the axilla in select patients. In the era of patient/tumor specific management, the advent of molecular and genomic profiling is a paradigm shift in the treatment of a biologically heterogenous disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022152 · Cited by 6,249
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6529 · Cited by 4,213
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Giuliano, A. E. (2011) · JAMA · doi:10.1001/jama.2011.90 · Cited by 2,942
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, A., Pawlicki, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910383 · Cited by 2,775
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Cheang, M. C. U., Chia, S. K., Voduc, D., Gao, D., Leung, S., Snider, J., Watson, M., Davies, S., Bernard, P. S., Parker, J. S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp082 · Cited by 2,249
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
Veronesi, U., Paganelli, G., Viale, G., Luini, A., Zurrida, S., Galimberti, V., Intra, M., Veronesi, P., Robertson, C., Maisonneuve, P., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa012782 · Cited by 2,210
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
Allred, D. C., Harvey, J. M., Berardo, M. D., & Gm, C. (1998) · PubMed · Cited by 2,143
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Rastogi, P., Anderson, S. J., Bear, H. D., Geyer, C. E., Kahlenberg, M. S., Robidoux, A., Margolese, R. G., Hoehn, J. L., Vogel, V. G., Dakhil, S. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0235 · Cited by 1,789
Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998
Preston, D. L., Ron, E., Tokuoka, S., Funamoto, S., Nishi, N., Soda, M., Mabuchi, K., & Kodama, K. (2007) · Radiation Research · doi:10.1667/rr0763.1 · Cited by 1,753
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674
Berg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
Reproductive Factors and Breast Cancer
Kelsey, J. L., Gammon, M. D., & John, E. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036115 · Cited by 1,446
Fisher, B., Jeong, J.-H., Anderson, S., Bryant, J., Fisher, E. R., & Wolmark, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020128 · Cited by 1,400
Danaei, G., Vander Hoorn, S., Lopez, A. D., Murray, C. J., & Ezzati, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67725-2 · Cited by 1,367
A breast cancer prediction model incorporating familial and personal risk factors
Tyrer, J., Duffy, S. W., & Cuzick, J. (2004) · Statistics in Medicine · doi:10.1002/sim.1668 · Cited by 1,345
Henderson, I. C., Berry, D. A., Demetri, G. D., Cirrincione, C. T., Goldstein, L. J., Martino, S., Ingle, J. N., Cooper, M. R., Hayes, D. F., Tkaczuk, K. H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.063 · Cited by 1,294
Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force
Nelson, H. D., Tyne, K., Naik, A., Bougatsos, C., Chan, B. K., & Humphrey, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00009 · Cited by 1,248
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
Voduc, K. D., Cheang, M. C. U., Tyldesley, S., Gelmon, K., Nielsen, T. O., & Kennecke, H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9284 · Cited by 1,243
Cheang, M. C. U., Voduc, D., Bajdik, C., Leung, S., McKinney, S., Chia, S. K., Perou, C. M., & Nielsen, T. O. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1658 · Cited by 1,195
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.7.e48 · Cited by 1,042
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
Claus, E. B., Risch, N., & Thompson, W. D. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-5 · Cited by 942
Benign Breast Disease and the Risk of Breast Cancer
Hartmann, L. C., Sellers, T. A., Frost, M. H., Lingle, W. L., Degnim, A. C., Ghosh, K., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., Hillman, D. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044383 · Cited by 938
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.6.907 · Cited by 895
The ATAC (Arimidex, T. A. O. I. C. T. G. (2003) · Cancer · doi:10.1002/cncr.11745 · Cited by 861
Treatment of Early-Stage Breast Cancer
(1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460030097037 · Cited by 782
Implementation of the women's health initiative study design
Anderson, G. L., Manson, J., Wallace, R., Lund, B., Hall, D., Davis, S., Shumaker, S., Wang, C.-Y., Stein, E., & Prentice, R. L. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00043-7 · Cited by 756
Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
Parmigiani, G., Berry, D. A., & Aguilar, O. (1998) · The American Journal of Human Genetics · doi:10.1086/301670 · Cited by 753
The Breast Cancer Susceptibility Collaboration (UK), Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1902 · Cited by 746
Mamounas, E. P., Bryant, J., Lembersky, B., Fehrenbacher, L., Sedlacek, S. M., Fisher, B., Wickerham, D. L., Yothers, G., Soran, A., & Wolmark, N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.517 · Cited by 714
Mamounas, E. P., Tang, G., Fisher, B., Paik, S., Shak, S., Costantino, J. P., Watson, D., Geyer, C. E., Wickerham, D. L., & Wolmark, N. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7610 · Cited by 619
Rockhill, B., Spiegelman, D., Byrne, C., Hunter, D. J., & Colditz, G. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.5.358 · Cited by 618
Gianni, L., Dafni, U., Gelber, R. D., Azambuja, E., Muehlbauer, S., Goldhirsch, A., Untch, M., Smith, I., Baselga, J., Jackisch, C., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70033-x · Cited by 612
Lahmann, P. H., Hoffmann, K., Allen, N., van Gils, C. H., Khaw, K., Tehard, B., Berrino, F., Tjønneland, A., Bigaard, J., Olsen, A., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20315 · Cited by 580
Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer
Warner, E., Messersmith, H., Causer, P., Eisen, A., Shumak, R., & Plewes, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-9-200805060-00007 · Cited by 564
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Li, J., Ho, G. Y. F., Xue, X., Anderson, G. L., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn415 · Cited by 563
Sentinel Lymph Node Biopsy in Breast Cancer: Ten-Year Results of a Randomized Controlled Study
Veronesi, U., Viale, G., Paganelli, G., Zurrida, S., Luini, A., Galimberti, V., Veronesi, P., Intra, M., Maisonneuve, P., Zucca, F., et al. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181c0e92a · Cited by 551
Cancer Risks and Mortality in Heterozygous ATM Mutation Carriers
Thompson, D., Duedal, S., Kirner, J., McGuffog, L., Last, J., Reiman, A., Byrd, P., Taylor, M., & Easton, D. F. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji141 · Cited by 543
Anderson, B. O., Yip, C.-H., Smith, R. A., Shyyan, R., Sener, S. F., Eniu, A., Carlson, R. W., Azavedo, E., & Harford, J. (2008) · Cancer · doi:10.1002/cncr.23844 · Cited by 533
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia
Dupont, W. D., Parl, F. F., Hartmann, W. H., Brinton, L. A., Winfield, A. C., Worrell, J. A., Schuyler, P. A., & Plummer, W. D. (1993) · Cancer · doi:10.1002/1097-0142(19930215)71:4<1258::aid-cncr2820710415>3.0.co;2-i · Cited by 528
Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk
Chen, W. Y., Rosner, B., Hankinson, S. E., Colditz, G. A., & Willett, W. C. (2011) · JAMA · doi:10.1001/jama.2011.1590 · Cited by 509
Berry, D. A., Iversen, E. S., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., Lerman, C., Watson, P., Lynch, H. T., Hilsenbeck, S. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.121 · Cited by 505
Periodic Breast Cancer Screening in Reducing Mortality From Breast Cancer
Shapiro, S. (1971) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1971.03180240027005 · Cited by 499
Kelly, K. M., Dean, J., Comulada, W. S., & Lee, S.-J. (2010) · European Radiology · doi:10.1007/s00330-009-1588-y · Cited by 497
Colditz, G. A. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.950 · Cited by 487
Physical activity and risk of breast cancer: a meta-analysis of prospective studies
Wu, Y., Zhang, D., & Kang, S. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2396-7 · Cited by 424
Hsieh, C., Trichopoulos, D., Katsouyanni, K., & Yuasa, S. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460508 · Cited by 421
De Laurentiis, M., Cancello, G., D'Agostino, D., Giuliano, M., Giordano, A., Montagna, E., Lauria, R., Forestieri, V., Esposito, A., Silvestro, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3787 · Cited by 416
Houssami, N., Macaskill, P., Marinovich, M. L., Dixon, J. M., Irwig, L., Brennan, M. E., & Solin, L. J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.043 · Cited by 406
Regular self-examination or clinical examination for early detection of breast cancer
Kösters, J. P., & Gøtzsche, P. C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003373 · Cited by 372
Reproductive Risk Factors in a Prospective Study of Breast Cancer: The Nurses' Health Study
Rosner, B., Colditz, G. A., & Willett, W. C. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117079 · Cited by 371
NCCN breast cancer clinical practice guidelines in oncology: an update.
Carlson, R. W. (2003) · PubMed · Cited by 329
Amir, E., Evans, D. G., Shenton, A., Lalloo, F., Moran, A., Boggis, C., Wilson, M., & Howell, A. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.11.807 · Cited by 308
Chang, J. H., Vines, E., Bertsch, H., Fraker, D. L., Czerniecki, B. J., Rosato, E. F., Lawton, T., Conant, E. F., Orel, S. G., Schuchter, L., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010401)91:7<1231::aid-cncr1123>3.0.co;2-k · Cited by 297
NIH consensus conference. Treatment of early-stage breast cancer
(1991) · JAMA · doi:10.1001/jama.265.3.391 · Cited by 258
Ravdin, P. M., & Chamness, G. C. (1995) · Gene · doi:10.1016/0378-1119(94)00866-q · Cited by 254
Henderson, T. O., Amsterdam, A., Bhatia, S., Hudson, M. M., Meadows, A. T., Neglia, J. P., Diller, L. R., Constine, L. S., Smith, R. A., Mahoney, M. C., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-7-201004060-00009 · Cited by 251
Multidisciplinary breast cancer clinics: Do they work?
Gabel, M., Hilton, N. E., & Nathanson, S. D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2380::aid-cncr12>3.0.co;2-n · Cited by 243
Sharif, S., Moran, A., Huson, S. M., Iddenden, R., Shenton, A., Howard, E., & Evans, D. G. R. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.049346 · Cited by 242
Insulin receptor expression and function in human breast cancer cell lines.
Milazzo, G., Giorgino, F., Damante, G., Sung, C., Stampfer, M. R., Vigneri, R., Goldfine, I. D., & Belfiore, A. (1992) · PubMed · Cited by 206
Chlebowski, R. T., Manson, J. E., Anderson, G. L., Cauley, J. A., Aragaki, A. K., Stefanick, M. L., Lane, D. S., Johnson, K. C., Wactawski-Wende, J., Chen, C., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt043 · Cited by 205
Family history and risk of breast cancer: nurses’ health study
Colditz, G. A., Kaphingst, K. A., Hankinson, S. E., & ROSNER, B. A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1985-9 · Cited by 204
Lalloo, F., & Evans, D. G. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01859.x · Cited by 202
Ritte, R., Lukanova, A., Berrino, F., Dossus, L., Tjønneland, A. M., Olsen, A., Overvad, T. F., Overvad, K., Clavel‐Chapelon, F., Fournier, A., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3186 · Cited by 146
Boughey, J. C., Hartmann, L. C., Anderson, S. S., Degnim, A. C., Vierkant, R. A., Reynolds, C. A., Frost, M. H., & Pankratz, V. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0784 · Cited by 143
Validity of Models for Predicting BRCA1 and BRCA2 Mutations
Parmigiani, G., Chen, S., Iversen, E. S., Friebel, T. M., Finkelstein, D. M., Anton-Culver, H., Ziogas, A., Weber, B. L., Eisen, A. F., Malone, K. E., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00002 · Cited by 140
de Bock, G. H., Bonnema, J., van der Hage, J. A., Kievit, J., & van de Velde, C. J. H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.080 · Cited by 132
On the efficacy of screening for breast cancer
Freedman, D. A. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyg275 · Cited by 128
Sieri, S., Krogh, V., BOLELLI, G., Abagnato, C. A., Grioni, S., Pala, V. M., Evangelista, A., Allemani, C., Micheli, A., Tagliabue, G., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0808 · Cited by 127
Optimal Selection of Individuals for BRCA Mutation Testing: A Comparison of Available Methods
James, P. A., Doherty, R. J., Harris, M., Mukesh, B. N., Milner, A. D., Young, M., & Scott, C. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.9737 · Cited by 120
Jacobi, C. E., de Bock, G. H., Siegerink, B., & van Asperen, C. J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0070-x · Cited by 116
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.
Euhus, D., Smith, K. C., Robinson, L., Stucky, A., Olopade, O., Cummings, S., Garber, J., Chittenden, A., Mills, G., Rieger, P., et al. (2002) · Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.844 · Cited by 114
Breast cancer in Belarus and Ukraine after the Chernobyl accident
Pukkala, E., Kesminiene, A., Polyakov, S. L., Ryzhov, A., Drozdovitch, V., Kovgan, L. N., Kyyrönen, P., Malakhova, I. V., Gulak, L., & Cardis, E. (2006) · International Journal of Cancer · doi:10.1002/ijc.21885 · Cited by 111
Wong‐Brown, M. W., Nordfors, C., Mossman, D., Pecenpetelovska, G., Avery‐Kiejda, K. A., Talseth‐Palmer, B. A., Bowden, N. A., & Scott, R. J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1443-0 · Cited by 105
Meyers, M. O., Klauber‐DeMore, N., Ollila, D. W., Amos, K. D., Moore, D. T., Drobish, A. A., Burrows, E. M., Dees, E. C., & Carey, L. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1665-8 · Cited by 98
Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer
Buist, D. S. M., Abraham, L., Barlow, W. E., Krishnaraj, A., Holdridge, R. C., Sickles, E. A., Carney, P. A., Kerlikowske, K. M., & Geller, B. M. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1106-6 · Cited by 87
Graphs to estimate an individualized risk of breast cancer.
Bénichou, J., Gail, M. H., & Mulvihill, J. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.103 · Cited by 80
Current status of adjuvant systemic therapy for primary breast cancer: progress and controversy
Hortobágyi, G. N., & Buzdar, A. U. (1995) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.45.4.199 · Cited by 80
Gartlehner, G., Thaler, K. J., Chapman, A. L., Kaminski-Hartenthaler, A., Berzaczy, D., Noord, M. V., & Helbich, T. H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009632.pub2 · Cited by 79
Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology
(2003) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2003.0023 · Cited by 16
(1977) · doi:10.1002/1097-0142(197706)39:6<2772::aid-cncr2820390665>3.0.co;2-k
Cited by
Awareness and current knowledge of breast cancer
Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017) · Biological Research · doi:10.1186/s40659-017-0140-9 · Cited by 1,406
Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer
Kumar, N., Gulati, H. K., Sharma, A., Heer, S., Jassal, A. K., Arora, L., Kaur, S., Singh, A., Bhagat, K., Kaur, A., et al. (2021) · Molecular Diversity · doi:10.1007/s11030-020-10133-y · Cited by 37
Metadata
- Authors
- Shah, R.
- Venue
- World Journal of Clinical Oncology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 5
- Issue
- 3
- Pages
- 283
- ISSN
- 2218-4333 (ISSN-L)
- OpenAlex
- W1973387286
- Cited by
- 329
- References
- 110
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.